๐ข ๐๐๐๐๐ง๐ญ๐ฅ๐ฒ ๐ฉ๐ฎ๐๐ฅ๐ข๐ฌ๐ก๐๐
I'm pleased to share our latest policy paper, which brings together insights from clinicians, health economists, outcomes researchers, and policy experts to address critical gaps in early-stage #cancercare.
Access the article in full here ๐ bit.ly/485EbYI
#healthpolicy #HEOR
Image of ISPOR's US Healthcare System brochure cover
ISPOR launched content providing an overview of the US healthcare system. The โUS Healthcare System Overviewโ website outlines one of the most complex healthcare systems in the world. #healthcare #HEOR
https://ow.ly/WStt50YwNEq
Text: ISPOR: May 17 - 20, 2026 | Philadelphia, USA. Lumanity is going to ISPOR 2026! Meet the team at booth #624. Lumanity logo.
Heading to ISPOR 2026 in Philadelphia this May? We are too!
The Lumanity team will be on-site at booth #624, ready to help you navigate evolving policy shifts, shape compelling value stories, and share insights.
Find out more on our website: lumanity.com/events/ispor...
#ISPOR2026 #HEOR #RWE #HTA
The Most Favored Nation policy: early insights into Europeโs response to President Trump's executive order on medicine pricing
www.pharmaceutical-technology.com/analyst-comm...
#pharma #heor
v0.16.3 of the #rstats #eq5d package is now on #CRAN. The release includes the new EQ-5D-5L value set for UK and the EQ-5D-Y-3L value set for Hong Kong.
More info and examples of how to use it at github.com/fragla/eq5d and cran.r-project.org/package=eq5d.
@euroqol.bsky.social
#heor #hta
Bullet-point summary of study
US-based analysis finds that shortening ART restart delays from 32 to 12 weeks results in 88 transmissions averted and lifetime healthcare savings of $101 million by improving viral suppression and CD4 counts. #HEOR #HIV #ART #PublicHealth
Graphic in white and pink. There is a headshot of Andria Joseph. The quoted text reads: "It is exciting to see the publication of the new UK EQ-5D-5L value set in Value in Health. For those working across HEOR, HTA and market access, this is a significant development for the UK evidence landscape. For HEOR, this matters because the choice of value set can directly influence utility estimates, QALY calculations and, ultimately, the results of economic evaluations." Andria Joseph, Project Director. The YHEC 40th anniversary logo also features
It is great to see the publication of the new UK EQ-5D-5L value set in Value in Health. For those working across HEOR, HTA and market access, this is an important development for the UK evidence landscape.
Want to discuss what this means? Get in touch: www.yhec.co.uk/contact-us/
#HEOR #HTA #EQ5D
Excited to share our latest research article that compares the cost-effectiveness of #๐ซ๐ข๐๐จ๐๐ข๐๐ฅ๐ข๐ versus #๐ฉ๐๐ฅ๐๐จ๐๐ข๐๐ฅ๐ข๐ as first-line treatment for HR+/HER2โadvanced breast cancer in postmenopausal women from a Medicare perspective.
Read the full article here ๐ bit.ly/4szheFD
#HealthEconomics #HEOR
๐ Master Pharma Market Access & Pricing โ the key to successful drug commercialization!
Learn global access strategy, pricing models, HTA, HEOR & payer negotiations.
๐ zurl.co/UxjwE
#PharmaMarketAccess #PricingStrategy #HEOR #RoyedTraining
While clean-fuel households in Nigeria spend more for cooking energy and respiratory health care than those using polluting fuels, a model-based analysis showed clean fuels to be cost-effective. #CleanFuel #Nigeria #HEOR
Overhaul to UK medicine regulation is set to see MHRA and NICE decisions for new drugs arrive at the same time
www.pharmaceutical-technology.com/news/mhra-an...
#pharma #heor
Catch the latest news on the HEOR News Desk! Current headlines feature the release of the new #HEOR competencies framework; scaling proven interventions to add healthy life years; the #QALY paradox; & more >> https://ow.ly/ljPl50YtEAv
Retrospective commercial claims analysis of patients with congenital pulmonary valve disease through age 65 quantifies the lifelong burden. High early hospitalization rates and average cumulative lifetime costs exceeding $2 million by age 65 underscore the need for improved early care. #HEOR
This study examined the effect of head and neck cancer (HNC) treatment on household financial vulnerability and potential need for catastrophic income loss protection. HNC carries high morbidity, and treatment can cause serious functional impairment. A cross-sectional simulation used responses from US adults aged 35โ64 in the US Federal Reserve 2023 SHED survey. With complete income loss, 16% of simulated patients were insolvent by 3 months, increasing sharply to nearly half by 6 months. Partial income loss substantially reduced insolvency risk, while access to liquid savings further protected households from short-term financial collapse during treatment. Results highlight severe financial vulnerability during HNC care, supporting expanded income protection programs and broader evaluation of cancer-related household hardship.
New in JHEOR: Head and neck cancer treatment causes rapid household insolvency risk, highlighting need for income protection programs, based on simulation using US survey data. jheor.org/article/155597 #HEOR #CancerTreatment #CatastrophicIllness
Excited to share our latest research, โEffect Modification by Multimorbidity Burden on Effectiveness & Safety of SGLT2i in Older T2D Adults: A TTE studyโ at ISPOR 2026 (Philly, PA)!@ispor.bsky.social
Poster Session 5, CO167
05/20 (Wed) 9-11:30 AM
Discussion: 9-10 AM
See you there๐
#ISPOR #HEOR #RWE
This study examined antiretroviral therapy switching patterns among treatment-experienced people with HIV to inform shared decision-making and optimize long-term regimen selection.
New Optum claims analysis finds that treatment-experienced people with HIV receiving bictegravir/emtricitabine/tenofovir had greater regimen durability and lower switching risk than other antiretroviral therapies, including Medicare Advantage populations. jheor.org/article/156180 #HEOR #HIV #ART
Catch the latest news on the HEOR News Desk! Current headlines feature the release of the top 10 #HEOR trends list; rising demands for evidence amid #HealthPolicy uncertainty; AI in HEOR & #healthcare decision making; climate change impacts; & more >> https://ow.ly/8I3Z50Yinog
Graphic in orange and grey. There is a photo of a recycling symbol made from green leaves (three green arrows in a circle). The text reads: New publication. Implications of incorporating environmental sustainability into HTA for digital health technologies. Value in Health. The YHEC 40th anniversary logo is in the top left hand corner.
Can digital health deliver value for patients and the planet?
YHEC's Melissa Pegg is co-author of a new commentary in Value in Health exploring embedding environmental sustainability in HTA for digital health technologies:
www.valueinhealthjournal.com/article/S109...
#HEOR #DigitalHealth
Great pleasure visiting ISPOR HQ today! @ispor.bsky.social
Thanks so much for the dearest hosting from Dr Laura Pizzi and the whole ISPOR team! Absolutely a blast with ISPOR & Rutgers HOPE/RPIF HEOR.
Canโt wait to see you all again in the ISPOR 2026 in Philly this May ๐
#ISPOR #HEOR #Rutgers
New modeling study: QALY-based cost-effectiveness analyses undervalue life-extending Duchenne muscular dystrophy treatments, favoring delayed progression over mortality gains and highlighting limitations of traditional value frameworks. #HEOR #qalys #musculardystrophy jheor.org/article/156118
#Wednesday #WednesdayVibes #HumpDay #4040rec #medicalsalesjobs #BusinessDevelopment #commercial #territorymanagement #marketaccess #marketing #leadership #peoplemanagement #pharmaceuticals #ukjobs #HEOR #pharmainsights #healthcareinsights #marketresearch #healthcare #medtech #biotech #healthtech
New in JHEOR: A lifetime Markov model showed that adjuvant trastuzumab-emtansine is cost-effective and cost-saving vs trastuzumab for HER2+ breast cancer with residual disease in Colombia. jheor.org/article/156056 #HEOR #breastcancer
ISPOR just published its #HEOR Competencies Framework! #HEOR #healthcare
ISPOR Health Economics and Outcomes Research (HEOR) Competencies Framework brochure cover
News! ISPOR publishes Health Economics and Outcomes Research (HEOR) Competencies Framework. This new resource guides HEOR professionals in their career development. #HEOR #healthcare
https://ow.ly/7rXo50Y8NZw
ISPOR - The Professional Society for Health Economics and Outcomes Research is officially on Bluesky! #HEOR #ISPOR #healthcare
ISPOR is now on Bluesky! We're looking forward to the conversations. #HEOR #ISPOR #ImprovingHealthcareDecisions
Patient interviews within a phase 1/2 open-label trial show that DTX401 gene therapy reduces treatment burden and improves quality of life in adults with glycogen storage disease type Ia (GSDIa). jheor.org/article/155666 #HEOR #GSDIa #genetherapy
#Wednesday #WednesdayVibes #HumpDay #4040rec #medicalsalesjobs #BusinessDevelopment #commercial #territorymanagement #marketaccess #marketing #leadership #peoplemanagement #pharmaceuticals #ukjobs #HEOR #pharmainsights #healthcareinsights #marketresearch #healthcare #medtech #biotech #healthtech
๐ฃRecommended reading๐ฃ
Our latest paper assesses the relationship between #Alkalinephosphatase levels, #healthcareresourceutilisation, and costs in #๐ฑ๐ณ๐ช๐ฎ๐ข๐ณ๐บ๐ฃ๐ช๐ญ๐ช๐ข๐ณ๐บ๐ค๐ฉ๐ฐ๐ญ๐ข๐ฏ๐จ๐ช๐ต๐ช๐ด patients in the US.
View the full article here ๐ bit.ly/4aLMEB5
#healtheconomics #HEOR #economicimpact
